Results 151 to 160 of about 5,827 (204)

OSBPL2-mediated lipid metabolism alteration governs lung cancer stem cells properties. [PDF]

Stem Cell Res Ther
Liu H, Yin P, Bian G, Xu C, Wang Y.
europepmc   +1 more source

Secreted lumican from the tumor microenvironment potentiates HCC stemness and progression. [PDF]

Hepatol Commun
Chan KK, Wong CY, Au KY, Suen LH, Yip WW, Zhang JM, Fung EY, Lee TK, Ng IO, Cheung TT, Lo RC.   +10 more
europepmc   +1 more source

Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer Therapy. [PDF]

Int J Mol Sci
Jones AP, Zhao Y, Rueda BR, Yeku OO, Xu L.   +4 more
europepmc   +1 more source

Bufalin Suppresses Triple-Negative Breast Cancer Stem Cell Growth by Inhibiting the Wnt/β-Catenin Signaling Pathway. [PDF]

J Microbiol Biotechnol
Park SJ, Jung HJ.
europepmc   +1 more source

OSBPL3-driven sterol metabolic reprogramming promotes oncogenic signaling and therapeutic resistance in pancreatic cancer. [PDF]

Theranostics
Sun Q, Li X, Zou Q, Chen Y, Zhu X, Jiang H, Jiang T, Wei F, Xie K.   +8 more
europepmc   +1 more source

Optimum Serum Concentration Enhances Migration of MDA-MB-231 Triple-Negative Breast Cancer Cells and Promotes Intracellular Delivery of Proapoptotic Domain via Cell-Penetrating Peptides. [PDF]

Mol Pharm
Araki Y, Takatani-Nakase T, Ninomiya S, Matsumoto M, Hirose H, Kawaguchi Y, Fujiwara D, Michigami M, Katoh H, Wada T, Futaki S, Fujii I, Hagiwara M, Nakase I.   +13 more
europepmc   +1 more source

The lysosomal cysteine protease cathepsin L promotes stemness and multidrug resistance of non-small cell lung cancer by targeting HGF activator. [PDF]

Mol Cell Biochem
Shi H, Xu J, Wu J, Hu S, Chen X, Hu Q, Liu Q, Yu Y, Ding X, Wang W.   +9 more
europepmc   +1 more source

The MALAT1-EZH2 axis regulates PRC2 activity and promotes the mesenchymal phenotype in pediatric atypical teratoid/rhabdoid tumors. [PDF]

J Neurooncol
Gurbuz M, Tekin C, Ercelik M, Koc SA, Kockar F, Eser P, Taskapilioglu MO, Tezcan G, Erbaykent B, Bekar A, Kocaeli H, Ozsen M, Karabaglı P, Karabaglı H, Bayrak BY, Etus V, Tunca B.   +16 more
europepmc   +1 more source

CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer. [PDF]

NPJ Precis Oncol
Makovec A, Boytim E, Gustafson A, Ludwig M, Wang L, Ali A, Ishani K, Luo C, Bergom HE, John E, Tape S, Kellen S, Deacon A, Dewji FI, Richter C, Cookle L, Moline D, Rennhack JP, Drake JM, Antonarakis ES, Largaespada DA, Ostrander JH, Hwang J.   +22 more
europepmc   +1 more source

CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer. [PDF]

Oncotarget
Makovec A, Phoenix JT, Bergom HE, Boytim E, Gustafson AP, Deacon A, Tape S, Ali A, Ludwig M, Pitzen SP, Moline D, Richter C, Longie H, Su MC, Jena S, Likasitwatanakul P, Drake JM, Huang RS, Hahn WC, Rennhack JP, Dehm SM, Kregel S, Antonarakis ES, Hwang J.   +23 more
europepmc   +1 more source